Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Trinity Biotech (TRIB) Other Gross PP&E Adjustments (2016 - 2025)

Trinity Biotech's Other Gross PP&E Adjustments history spans 17 years, with the latest figure at $4.3 million for Q2 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 10.32% to $4.3 million in Q2 2025 year-over-year; TTM through Jun 2025 was $4.3 million, a 10.32% increase, with the full-year FY2024 number at $4.6 million, up 144.24% from a year prior.
  • Other Gross PP&E Adjustments hit $4.3 million in Q2 2025 for Trinity Biotech, down from $4.6 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for TRIB hit a ceiling of $8.6 million in Q1 2021 and a floor of $1.8 million in Q3 2023.
  • Historically, Other Gross PP&E Adjustments has averaged $4.8 million across 5 years, with a median of $5.5 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 70.34% in 2023 and later skyrocketed 144.24% in 2024.
  • Tracing TRIB's Other Gross PP&E Adjustments over 5 years: stood at $5.9 million in 2021, then fell by 3.99% to $5.7 million in 2022, then plummeted by 66.7% to $1.9 million in 2023, then surged by 144.24% to $4.6 million in 2024, then decreased by 6.75% to $4.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for TRIB at $4.3 million in Q2 2025, $4.6 million in Q4 2024, and $3.8 million in Q3 2024.